HOME
ABOUT MORSE
The Team
Careers
SERVICES
Our Services
Strategic Advice
MORSE pCPA Assessment
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
RWE/Innovative Agreements
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Pre-order 2024 CRaFT Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Careers
SERVICES
Our Services
Strategic Advice
MORSE pCPA Assessment
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
RWE/Innovative Agreements
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Pre-order 2024 CRaFT Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
pre-NOC
All the posts published.
New Drug Submission Guidelines in Quebec
June 8, 2017
-
Market Access News
-
Posted by
MORSE Team
INESSS Introduces New Pre-NOC and Biosimilar Guidance The Institut national d'excellence en santé et en services sociaux (INESSS) released its new submission guidelines on June 2nd, 2017. The guidelines, which are now effective, include revised and new Form applications and letter templates for drug submissions. The two major highlights relate to pre-NOC review and the introduction of new guidelines for biosimilar submissions. Pre-NOC Review Unlike the CADTH pre-NOC guidelines…
Read More →
pre-NOC - Info and details on - MORSE Consulting Inc.